Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19
NCT ID: NCT04417374
Last Updated: 2020-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
94 participants
OBSERVATIONAL
2020-05-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.
By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.
It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.
This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Impact of Confinement on the Adult
NCT04353570
COVID-19 - No Health Without Mental Health
NCT04421612
Investigating Differential Effects of Online Mental Training Interventions on Mental Well-being and Social Cohesion
NCT04889508
Positive Psychology in Suicidal Patients
NCT02855736
Long-term Quality of Life and Prognostic Factors in Severe COVID-19 Patients and Their Relatives
NCT05520047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives :
* Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
* Assess the lengh of the hospitalization
* Assess the number of patients hospitalized without psychiatric antecedent
* Assess the number of treatment interruptions in the recent history before hospitalization
* Asses the number of patients living alone
* Asses the number of patients using drugs
It is expected to highlight :
* An increase of the number of unvontuntary commitment
* If one or several mental disorders were more at risk of requiring an unvonluntary commitment
* An increased lengh of hospitalization
* An increased number of unvonluntary commitment of patients without psychiatric antecedent
* An increased number of treatment interruptions
* A link between hospitalization and living alone
* A link between hospitalization and using drugs
The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.
The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unvonluntary commitment from March 12th to April 09th 2019
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019
Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Unvonluntary commitment from March 12th to April 09th 2020
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020
Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emilie Olie, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL20_0320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.